Lexaria Bioscience : Corporate Highlight Sheet
LEXARIA BIOSCIENCE CORP. NASDAQ: LEXX INVESTOR CONTACT Phone: 250-765-6424 ext. 202...
Source: marketscreener.com
📰 Data From This Human Study News
Data From This Human Study News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Data From This Human Study. Real-time updates on events, politics, business and more.
Lexaria Bioscience Corp.: Lexaria's Pulmonary Hypertension Clinical Study HYPER-H21-3 Delivers Positive Results
Data From This Human Study, Together With the Findings From Lexaria's Other Previously Announced Successful Studies, Intended To Support the Company's Plans To Seek Approvals by the U.S. Food and Drug
George Jurcic Exchange Commission Lexaria Bioscience Corp Company Or Lexaria Company Plans To Seek Approvals Drug Administration
Source: finanznachrichten.de